MSB 1.30% $2.27 mesoblast limited

MSB Trading 2021 - paradigm shift, page-61

  1. 1,064 Posts.
    lightbulb Created with Sketch. 210
    If this is the case, maybe this approach might be the way to go about getting their pound of flesh rather than the current slow-death by FDA controlled strangulation.

    Memo - 9-1 expert panel approval only to be squashed by the same organisation that sent them. pure BS.

    ARDS - Advised to ‘stop’ trial due to PROBABILITY of not reaching ~40% reduction compared to placebo group.!!! Pure BS.
    Common sense can recognise that in this pandemic to equal the placebo arm would be of more benefit to both Hositals, Covid sufferers, even the big pharma if one thinks about it ( ain’t going to sell meds to dead people).

    Unless Silviu has something else solid in the pipeline, writing is on the wall unless MSB or FDA change tact.

    Doesn’t make sense.
    Im backing Silviu . Here’s hoping a big announcement will come left of field.
    Last edited by Kerrybrad: 05/01/21
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.492B
Open High Low Value Volume
$2.29 $2.30 $2.26 $1.459M 639.2K

Buyers (Bids)

No. Vol. Price($)
22 60854 $2.26

Sellers (Offers)

Price($) Vol. No.
$2.28 41323 17
View Market Depth
Last trade - 11.27am 16/04/2021 (20 minute delay) ?
-0.030 ( 1.02 %)
Open High Low Volume
$2.27 $2.31 $2.26 106344
Last updated 11.52am 16/04/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.